Nebulized and Intravenous Colistin in Ventilator Associated-pneumonia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Few antimicrobials are available to treat ventilated associated pneumonia (VAP) caused by Gram negative multi-resistant (MDR) bacteria. Colimycin often remains the only active antibiotic. The aim of the study is to demonstrate the superiority of nebulized colimycin over intravenous colimycin to treat VAP caused by Gramnegative MDR bacteria.
Epistemonikos ID: ceba1a18affb918d493cace22fd8c60fa8b0d53b
First added on: May 17, 2024